Karin Johnson

Principal Researcher

Karin Johnson is a principal researcher in the Health Division at AIR. Her primary responsibilities include providing subject matter expertise to support healthcare innovation efforts, including data system modernization. Dr. Johnson applies her nearly 20 years of management and research experience to lead research and technical assistance teams in close collaboration with clients. Her portfolio of expertise includes bundled payment initiatives, care coordination best practices, health workforce studies, pharmacoepidemiology, and pragmatic trials.

Previously, Dr. Johnson was an epidemiologist at IQVIA and a researcher and project manager at Group Health Cooperative.

Karin Johnson
Expertise
Health
Health Data Analytics and Business Intelligence

Ph.D., Geography, University of Washington; M.S., Harvard School of Public Health

Contact Karin Johnson

+1.202.403.5000
Related Work
Female pharmacist helping a senior customer

No Signs COVID Disrupted Hypertension Medication Adherence for Medicare Beneficiaries, but Racial and Ethnic Disparities Persisted

28 Dec 2022
Findings from this brief suggest that steps by Medicare to relax prescribing requirements during the pandemic, such as allowing early refills and larger quantities of medication, likely helped maintain medication adherence for high blood pressure and prevent racial and ethnic disparities in adherence from worsening. ...
Older male patient with doctor, both wearing masks

Steep but Short: COVID-19 Pandemic-Related Spending Drop for Medicare Beneficiaries with Chronic Conditions

26 Oct 2022
This study examined how spending for different categories of Medicare services—inpatient, hospital outpatient, and professional providers, including physicians, physician assistants, clinical social workers, and nurse practitioners—changed from the start of the pandemic through the end of 2021. 
Older patient having a telehealth call with physician

Telehealth for Medicare Beneficiaries with Chronic Conditions: No Panacea for COVID-19 Pandemic Access Challenges

29 Jul 2022
Despite rapid growth spurred by the COVID-19 pandemic, telehealth visits offset less than half of the decline in in-person visits for elderly Medicare fee-for-service beneficiaries five chronic conditions. Additional research is needed to assess the impact of ending telehealth flexibilities on equitable healthcare access and quality. ...

Spotlight on Drug Pricing

11 Jan 2021
Millions of Americans can’t afford their prescription drugs and often resort to skipping doses or going without critical medications. AIR works with clients at the federal, state, and local levels to identify and implement policies to reduce the cost burden of prescription drugs for patients.